| Name | Loncastuximab |
|---|
| Description | Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL)[1][2]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |